Eli Lilly announced a partnership with chipmaker NVIDIA to build what it claims will be the “most powerful supercomputer ...

As Merck looks for growth opportunities ahead of Keytruda’s tumble over the patent cliff, the company’s future now looks a ...

EDP-323 significantly reduced mean viral load AUC by 85% and 87% in the high- and low-dose groups, respectively, compared ...

The drugmaker hopes an Nvidia-chip powered supercomputer will help it find new drugs and accelerate lengthy R&D timelines.

Organon stock plunged after CEO's exit and audit probe. Discover if its low valuation, global portfolio, and earnings ...

Icotrokinra demonstrated clinically meaningful outcomes at Week 28 in the Phase 2b ANTHEM-UC study in ulcerative colitis, with 31.7% of patients achieving clinical remission and 38.1% showing ...

Eli Lilly said on Tuesday it was collaborating with Nvidia to build a supercomputer to help with drug discovery and shorten ...

Partnership Allows for Dramatic Scale-Out by Leveraging Standardized Global Grid Data from Electricity Maps for Real-Time ...

Synthetic audience testing is here to stay, but its value depends on how it’s done. Resonance Read introduces a more behaviorally precise, evidence-based way forward.

The BIM-IOL system showed a 42% reduction in mean IOP and improved visual acuity, with no serious adverse events linked to ...

At LogiPharma USA, industry leaders from Tive, McKesson, and the broader healthcare logistics community discussed the sector’s transition from passive monitoring to real-time control, the growing ...

Phages are particularly advantageous anti-infectives as they are novel therapeutics, can target antibiotic-resistant bacteria ...